Insider · CIK 0001766653
Suzanne Foster
Files at UTL (UNITIL CORP), AHCO (AdaptHealth Corp.). First filing -, latest -.
Suzanne Foster files SEC Form 4 as CEO and director at UTL (UNITIL CORP), and also at AHCO (AdaptHealth Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Suzanne Foster has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | UTL UNITIL CORP | AGrant or award Common stock, no par value | +2,272 | $0.00 | $0 | 14,406 | 11 d ago |
| Jan 30, 2026 | AHCO AdaptHealth Corp. | AGrant or award Common Stock | +329,449 | $0.00 | $0 | 924,050 | Feb 3, 2026 |
| Oct 1, 2025 | UTL UNITIL CORP | AGrant or award Common stock, no par value | +2,435 | $47.22 | $115k | 12,134 | Oct 3, 2025 |
| Feb 1, 2025 | AHCO AdaptHealth Corp. | AGrant or award Common Stock | +271,090 | $0.00 | $0 | 594,601 | Feb 4, 2025 |
Questions about Suzanne Foster
Answered from the filings on this page, as of the latest one.
Is Suzanne Foster buying or selling?
Suzanne Foster has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Suzanne Foster's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Suzanne Foster has 0.
Where does Suzanne Foster file Form 4?
Suzanne Foster has filed Form 4 at UTL (UNITIL CORP); AHCO (AdaptHealth Corp.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.